DEUTSCHE BANK AG\ - MOMENTA PHARMACEUTICALS INC ownership

MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 132 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MOMENTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$7,548,000
+72.5%
143,825
+9.4%
0.01%
+66.7%
Q2 2020$4,376,000
+161.6%
131,521
+113.9%
0.00%
+200.0%
Q1 2020$1,673,000
-50.9%
61,492
-64.4%
0.00%
-50.0%
Q4 2019$3,404,000
+366.3%
172,598
+205.7%
0.00%
+100.0%
Q3 2019$730,000
-11.0%
56,462
-14.5%
0.00%
Q2 2019$820,000
-24.0%
66,041
-11.2%
0.00%
-100.0%
Q1 2019$1,079,000
+2.4%
74,386
-22.3%
0.00%0.0%
Q4 2018$1,054,000
-91.7%
95,675
-80.3%
0.00%
-75.0%
Q3 2018$12,771,000
+42.6%
485,705
+10.9%
0.00%
+33.3%
Q2 2018$8,955,000
+83.7%
437,960
+63.0%
0.00%
+50.0%
Q1 2018$4,875,000
+100.1%
268,694
+53.7%
0.00%0.0%
Q4 2017$2,436,000
+27.5%
174,820
+68.9%
0.00%
+100.0%
Q3 2017$1,911,000
+13.1%
103,516
+3.4%
0.00%0.0%
Q2 2017$1,690,000
+607.1%
100,120
+455.0%
0.00%
Q1 2017$239,000
-66.0%
18,039
-61.5%
0.00%
-100.0%
Q4 2016$703,000
-45.5%
46,795
-57.6%
0.00%0.0%
Q3 2016$1,290,000
-51.8%
110,449
-55.5%
0.00%
-50.0%
Q2 2016$2,677,000
+1.4%
248,009
-13.3%
0.00%0.0%
Q1 2016$2,640,000
-33.0%
285,974
+7.6%
0.00%
-33.3%
Q4 2015$3,943,000
-27.0%
265,836
-19.2%
0.00%
-25.0%
Q3 2015$5,400,000
-12.4%
329,146
+21.8%
0.00%0.0%
Q2 2015$6,162,000
+150.1%
270,207
+66.5%
0.00%
+100.0%
Q1 2015$2,464,000
+101.5%
162,331
+59.6%
0.00%
+100.0%
Q4 2014$1,223,000
-41.5%
101,681
-44.8%
0.00%0.0%
Q3 2014$2,090,000
-48.7%
184,340
-45.4%
0.00%
-66.7%
Q2 2014$4,076,000
+1.2%
337,466
-2.6%
0.00%0.0%
Q1 2014$4,027,000
+220.6%
346,477
+387.2%
0.00%
+200.0%
Q4 2013$1,256,000
-49.4%
71,112
-58.8%
0.00%
-50.0%
Q3 2013$2,484,000172,6710.00%
Other shareholders
MOMENTA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of MOMENTA PHARMACEUTICALS INC shareholders